1 results match your criteria: "Hakodate Municipal Hospital. narito@hospital.hakodate.hokkaido.jp[Affiliation]"
[Study of thromboxane A2 antagonist reduction in the treatment of patients with perennial allergic rhinitis].
Arerugi
June 2004
Department of Otolaryngology, Hakodate Municipal Hospital.
Article Synopsis
- The study aimed to determine if the medication Ramatroban could be reduced for patients with perennial allergic rhinitis once their nasal symptoms improved.
- After administering Ramatroban for 4 weeks, significant improvements were observed in symptoms like sneezing, runny nose, and congestion, and these benefits persisted even after the dosage was halved for another 4 weeks.
- The research also showed a significant reduction in eosinophils in nasal smears, indicating decreased inflammation, supporting the idea that the medication dose can be lowered without losing effectiveness.